G.M. MEDICAL INVEST : revenue, balance sheet and financial ratios

G.M. MEDICAL INVEST is a French company founded 27 years ago, specialized in the sector Activités des sociétés holding. Based in LA MULATIERE (69350), this company of category PME shows in 2019 a revenue of 116 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - G.M. MEDICAL INVEST (SIREN 423373752)
Indicator 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 116 095 € 202 713 € 194 273 € 206 408 €
Net income 120 421 € 124 712 € 53 514 € 237 826 € 341 014 € 86 115 €
EBITDA N/C N/C -31 517 € -36 292 € -37 248 € -44 435 €
Net margin N/C N/C 46.1% 117.3% 175.5% 41.7%

Revenue and income statement

In 2021, G.M. MEDICAL INVEST generates positive net income of 120 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2021: 86 k€ -> 120 k€.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

120 421 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 20%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

19.86%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

68.771%

Solvency indicators evolution
G.M. MEDICAL INVEST

Sector positioning

Debt ratio
19.86 2021
2019
2020
2021
Q1: 0.13
Med: 15.19
Q3: 84.93
Average +5 pts over 3 years

In 2021, the debt ratio of G.M. MEDICAL INVEST (19.86) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
68.77% 2021
2019
2020
2021
Q1: 21.52%
Med: 60.87%
Q3: 89.3%
Good -13 pts over 3 years

In 2021, the financial autonomy of G.M. MEDICAL INVEST (68.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
2.86 years 2019
2019
Q1: -0.0 years
Med: 0.17 years
Q3: 4.06 years
Average

In 2019, the repayment capacity of G.M. MEDICAL INVEST (2.86) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 257.40. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

257.404

Liquidity indicators evolution
G.M. MEDICAL INVEST

Sector positioning

Liquidity ratio
257.4 2021
2019
2020
2021
Q1: 108.17
Med: 446.13
Q3: 2343.75
Average -17 pts over 3 years

In 2021, the liquidity ratio of G.M. MEDICAL INVEST (257.40) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-10.31x 2019
2019
Q1: -58.78x
Med: 0.0x
Q3: 0.0x
Average

In 2019, the interest coverage of G.M. MEDICAL INVEST (-10.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
G.M. MEDICAL INVEST

Positioning of G.M. MEDICAL INVEST in its sector

Comparison with sector Activités des sociétés holding

Valuation estimate

Based on 98 transactions of similar company sales in 2021, the value of G.M. MEDICAL INVEST is estimated at 577 216 € (range 195 207€ - 1 631 339€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2021
98 tx
195k€ 577k€ 1631k€
577 216 € Range: 195 207€ - 1 631 339€
NAF 5 année 2021

Valuation method used

Net Income Multiple
120 421 € × 4.8x = 577 216 €
Range: 195 208€ - 1 631 339€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 98 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des sociétés holding)

Compare G.M. MEDICAL INVEST with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des sociétés holding

Frequently asked questions about G.M. MEDICAL INVEST

What is the revenue of G.M. MEDICAL INVEST ?

The revenue of G.M. MEDICAL INVEST in 2019 is 116 k€.

Is G.M. MEDICAL INVEST profitable?

Yes, G.M. MEDICAL INVEST generated a net profit of 120 k€ in 2021.

Where is the headquarters of G.M. MEDICAL INVEST ?

The headquarters of G.M. MEDICAL INVEST is located in LA MULATIERE (69350), in the department Rhone.

Where to find the tax return of G.M. MEDICAL INVEST ?

The tax return of G.M. MEDICAL INVEST is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does G.M. MEDICAL INVEST operate?

G.M. MEDICAL INVEST operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.